首页> 外文期刊>Journal of cosmetic dermatology >Improvements in satisfaction with skin after treatment of facial fine lines with VYC‐12 injectable gel: Patient‐reported outcomes from a prospective study
【24h】

Improvements in satisfaction with skin after treatment of facial fine lines with VYC‐12 injectable gel: Patient‐reported outcomes from a prospective study

机译:用VYC-12注射凝胶治疗面部细纹后对皮肤满意的改善:患者报告的前瞻性研究结果

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Background VYC‐12, a hyaluronic acid injectable gel, is designed to treat fine lines and provides improvements in other skin quality attributes. A prospective study demonstrated the safety and effectiveness of VYC‐12 for the improvement of fine lines as measured by changes in skin texture. Aims To evaluate patient‐reported outcomes in subjects treated intradermally with VYC‐12 in the cheeks, forehead, and neck (optional) in the prospective study. Methods Subjects received an initial treatment of VYC‐12 (N?=?131), with a touch‐up treatment, if deemed necessary, offered 30?days later, and optional repeat treatment 9?months after initial or touch‐up treatment. Subjects completed the FACE‐Q Satisfaction With Skin scale and assessed willingness to recommend treatment to a friend at baseline, months 1, 4, 6, and 9, and month 1 after repeat treatment. Subjects also evaluated their return to normal daily social activities. Results Satisfaction with skin improved from baseline in 90.8% of subjects at month 1, 88.4% at month 4, 83.6% at month 6, 76.4% at month 9, and 91.9% at month 1 after repeat treatment ( P ??.001, all time points). At least 94% of subjects returned to normal daily social activities one day after treatment (initial, touch‐up, or repeat). More than 80% of subjects said they would recommend treatment to a friend at all time points through month 9 (97% at month 1 after repeat treatment). Conclusion Treatment with VYC‐12 significantly improved satisfaction with skin in the majority of subjects, with most subjects returning to normal activities 1?day after treatment.
机译:摘要背景VYC-12,透明质酸可注射凝胶,设计用于治疗细线并提供其他皮肤质量属性的改进。前瞻性研究证明了VYC-12的安全性和有效性,用于改善细纹,通过皮肤纹理的变化测量。旨在评估在前瞻性研究中的脸颊,额头和颈部(可选)在脸颊,额头和颈部(可选)中皮内治疗的受试者的患者报告的结果。方法受试者接受了VYC-12的初始治疗(n?= 131),如果认为必要的话,提升治疗,提供30-天后,并在初始或触摸治疗后的任选重复治疗9?月份。受试者以皮肤规模完成了面部Q满意度,并评估了在重复治疗后的基线,月1,4,6和9和月1日在基线上建议治疗的意愿。受试者还评估了他们恢复正常的日常社会活动。结果在11月1日,每月4,88.4%的90.8%受试者中,90.8%的基线提高了皮肤的满意度。 001,所有时间点)。至少94%的受试者在治疗后一天返回正常的日常社会活动(初始,触摸或重复)。超过80%的主题表示他们会在90点到9月9日之前向朋友提供治疗(在重复治疗后的第1月份97%)。结论VYC-12治疗在大多数受试者中对皮肤的满意度显着提高,大多数受试者返回正常活动1?治疗后一天。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号